Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2002
07/09/2002US6416951 Screening for functional antisense agents
07/09/2002US6416950 Linking nucleic acid reverse transcription primer which is bound to peptide acceptor to rna, translating rna to produce protein product covalently bound to primer, reverse transcribing rna to produce dna-protein fusion
07/09/2002US6416948 Isolating hematopoietic neoplastic cell containing target clonotypic nucleic acid rearrangement, amplifying specific segment of target, determining sequence of amplified segment, quantitatively detecting presence of rearrangement in cells
07/09/2002US6416945 Disassembling virus-like particles of l1 proteins or mixture of l1 and l2 proteins by contacting for prolonged time period with concentrated reducing agent solution, adding moiety to be encapsulated, reassembling by removing reducing agent
07/09/2002US6416755 Human beta-alanine-pyruvate aminotransferase
07/09/2002US6416641 Biosensor
07/09/2002CA2363662A1 Sequences and methods for detection of hiv-1
07/09/2002CA2328831A1 Antibiotics as quorum-sensing autoinducers
07/09/2002CA2264189C Homocysteine desulphurase from the protozoan trichomonas vaginalis
07/09/2002CA2236730C Textured surface for test sample cards and mold for manufacturing same
07/09/2002CA2186021C Purified dna polymerase from bacillus stearothermophilus
07/09/2002CA2133845C Adrenocorticotrophic hormone receptor and uses
07/09/2002CA2093804C Process and apparatus for fragmenting biomaterials
07/09/2002CA2042236C Seroreactive epitopes on proteins of human papillomavirus (hpv) 18
07/04/2002WO2002052275A2 Method for identifying blood cell hemostasis
07/04/2002WO2002052273A1 Screening method based on siah-numb interaction
07/04/2002WO2002052270A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
07/04/2002WO2002052269A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
07/04/2002WO2002052268A1 A screening assay for antagonists of human leukocyte receptors
07/04/2002WO2002052267A1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor
07/04/2002WO2002052266A1 Method of binding nucleic acid to diamond, diamond-mononucleoside conjugate and diamond-nucleic acid conjugate
07/04/2002WO2002052244A2 Separation of x- and y-sperm cells
07/04/2002WO2002052047A2 Methods for identifying g-protein coupled receptors associated with diseases
07/04/2002WO2002052046A2 Oligonucleotide transfection screening method
07/04/2002WO2002052044A2 Detection of genetic polymorphisms in genes associated with pharmacogenomics
07/04/2002WO2002052043A1 Method of detecting pathogenic microorganism
07/04/2002WO2002052041A2 5' nuclease nucleic acid amplification assay having an improved internal control
07/04/2002WO2002052040A2 Method for the simultaneous amplification of multiple sequences in a pcr reaction and marking thereof
07/04/2002WO2002052039A2 Methods for selecting and producing pharmaceutical compounds using a library responsive to transcription factors
07/04/2002WO2002052038A2 Method for normalizing the relative intensities of detection signals in hybridization arrays
07/04/2002WO2002052037A2 Method for screening and/or identifying factors that bind to nucleic acids
07/04/2002WO2002052036A2 Identification of modulators of dham-kinase and inflammatory diseases
07/04/2002WO2002052035A2 Methods for identification of inhibitors of cinnamyl alcohol dehydrogenase in plants
07/04/2002WO2002052034A1 Bioscopy method and method of nucleic acid amplification
07/04/2002WO2002052033A1 Pkc monocyte assay
07/04/2002WO2002052031A2 Nucleic acid amplification
07/04/2002WO2002052030A2 Compositions and methods enabling a totally internally controlled amplification reaction
07/04/2002WO2002052018A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/04/2002WO2002052016A2 Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme
07/04/2002WO2002052015A2 Self-replicating rna molecule from hepatitis c virus
07/04/2002WO2002052012A2 Sugar beet genes involved in stress tolerance
07/04/2002WO2002052006A1 Method of examining allergic disease
07/04/2002WO2002052004A1 Gene involved in apoptosis regulation
07/04/2002WO2002051999A1 Novel atopic dermatitis-associated gene and proteins
07/04/2002WO2002051998A1 Novel protease
07/04/2002WO2002051994A2 Polypeptides
07/04/2002WO2002051987A1 System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells
07/04/2002WO2002051981A2 Defects in periaxin associated with myelinopathies
07/04/2002WO2002051977A2 orfE-ZipA INTERACTION AND USES THEREOF
07/04/2002WO2002051868A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
07/04/2002WO2002051866A2 Antibacterial treatments
07/04/2002WO2002051864A1 Protein cluster ii
07/04/2002WO2002051858A2 Antisense modulation of chk2 expression
07/04/2002WO2002051857A1 Drug target isogenes: polymorphisms in the neuropeptide y gene
07/04/2002WO2002051853A1 Detection of microbial metabolites
07/04/2002WO2002051435A2 New therapeutic uses of smr1 peptides
07/04/2002WO2002051434A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
07/04/2002WO2002051430A2 Methods of modulating toll-related receptor (trr) signaling
07/04/2002WO2002051355A2 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action
07/04/2002WO2002051231A1 Genes of corynebacterium
07/04/2002WO2002040638A3 Mycologic genera specific selective agar and method of manufacture
07/04/2002WO2002036738A3 Affinity maturation by competitive selection
07/04/2002WO2002033116A3 Nucleic acid ligands to the prostate specific membrane antigen
07/04/2002WO2002033100A3 Regulation of human adenylate cyclase, type iv
07/04/2002WO2002031583A8 System and method for high numeric aperture imaging systems
07/04/2002WO2002031195A9 Assay for detecting and quantitating mouse t cell receptor excision circles
07/04/2002WO2002030951A3 Haplotypes of the cyp1b1 gene
07/04/2002WO2002029023A8 Nicastrin protein
07/04/2002WO2002027021A8 Method for detecting fungal infections
07/04/2002WO2002026988A9 Human drug metabolizing enzymes
07/04/2002WO2002021125A3 Drug discover employing calorimetric target triage
07/04/2002WO2002018626A8 Modulators of the interaction between arp2/3 and cortactin or hs-1
07/04/2002WO2002015949A8 Device for identifying the presence of a nucleotide sequence in a dna sample
07/04/2002WO2002012274A3 Iapl-3 a protein inhibitor of apoptosis proteins
07/04/2002WO2002010457A8 Targeting of dna sequences by the use of recombinase coated dna probes
07/04/2002WO2002004953A8 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
07/04/2002WO2002002624A3 B7-like molecules and uses thereof
07/04/2002WO2002000677A8 Nucleic acids, proteins, and antibodies
07/04/2002WO2001098525A3 Frozen tissue microarrays and methods for using the same
07/04/2002WO2001092492A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/04/2002WO2001090148A8 Neurotransmitter transporters
07/04/2002WO2001088089A3 Single copy genomic hybridization probes and method of generating same
07/04/2002WO2001084146B1 A sensitive, multiplexed mass-spectrometry-based biosensor based on immuno-pcr
07/04/2002WO2001084145B1 Device for monitoring analytes at sub-micromolar concentrations
07/04/2002WO2001083563A3 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha
07/04/2002WO2001079481A3 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides
07/04/2002WO2001079228A3 Haplotypes of the f12 gene
07/04/2002WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
07/04/2002WO2001070979A3 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
07/04/2002WO2001068855A3 Gtp-binding protein gamma-12 subunit
07/04/2002WO2001064886A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
07/04/2002WO2001059063A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055364A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055328A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055325A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055322A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055321A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055318A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055311A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055308A3 Nucleic acids, proteins, and antibodies